Publication | Open Access

Previous radiotherapy and the clinical activity and toxicity of pembrolizumab in the treatment of non-small-cell lung cancer: a secondary analysis of the KEYNOTE-001 phase 1 trial

Radiation MedicineRadiation TherapyMedicinePathologyKeynote-001 Phase 1Immune Checkpoint InhibitorCancer TreatmentOncologyRadiation OncologyPrevious RadiotherapyLung CancerClinical Activity